| 1) |
Echt DS, et al. Mortality and morbidity in patients receiving encainide, flecainide, or placebo. N Engl J Med 1991;324:781-8. |
| 2) |
Waldo AL, et al. Effect of d-sotalol on mortality in patients with left ventricular dysfunction after recent and remote myocardial infarction. Lancet 1996; 348:7-12. |
| 3) |
Amiodarone Trials Meta-analysis Investigators. Effect of prophylactic amiodarone on mortality after acute myocardial infarction and in congestive heart failure: meta-analysis of individual data from 6500 patients in randomised trials. Lancet 1997;350: 1417-24. |
| 4) |
Burkart F, et al. Effect of antiarrhythmic therapy on mortality in survivors of myocardial infarction with asymptomatic complex ventricular arrhythmias: Basel Antiarrhythmic Study of Infarct Survival (BASIS). J Am Coll Cardiol 1990;16:1711- 8. |
| 5) |
Singh SN, et al. Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. N Engl J Med 1995;333:77-82. |
| 6) |
Doval HC, et al. Randomised trial of low-dose amiodarone in severe heart failure. Lancet 1994;344:493-8. |
| 7) |
Garguichevich JJ, et al. Effect of amiodarone therapy on mortality in patients with left ventricluar dysfunction and asympatomatic complex ventricular arrhythmias: Argentine pilot study of sudden death and amiodarone (EPAMSA). Am Heart J 1995;130:494-500. |
| 8) |
Kuck KH, et al. Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest. The Cardiac Arrest Study Hamburg (CASH). Circulation 2000;102:748-54. |
| 9) |
The Antiarrhythmics Versus Implantable Defibrillators (AVID) Investigators. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med 1997;337:1576-83. |
| 10) |
Connolly SJ, et al. A randomized trial of the implantable defibrillator against amiodarone. AHA（1999年）で発表. |
| 11) |
Moss AJ, et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. N Engl J Med 1996;335:1933-40. |
| 12) |
Buxton AE, et al. A randomized study of the prevention of sudden death in patients with coronary artery disease. N Engl J Med 1999;341:1882-90. |
| 13) |
Bigger JT Jr. Prophylactic use of implanted cardiac defibrillators in patients at high risk for ventricular arrhythmia after coronary-artery bypass graft surgery. N Engl J Med 1997;337:1569-75. |
| 14) |
Hohnloser SH, et al. The defibrillator in acute myocardial infarction trial (DINAMIT): study protocol. Am Heart J 2000;140:735-9. |
| 15) |
Connolly SJ, et al. Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. Eur Heart J 2000;21:2071-8. |
| 16) |
Roy D, et al. Amiodarone to prevent recurrence of atrial fibrillation. N Engl J Med 2000;342:913-20. |
| 17) |
Deedwania PC, et al. Spontaneous conversion and maintenance of sinus rhythm by amiodarone in patients with heart failure and atrial fibrillation: observations from the veterans affairs congestive heart failure survival trial of antiarrhythmic therapy (CHF-STAT). Circulation. 1998 ;98:2574-9. |
| 18) |
Torp-Pedersen C, et al. Dofetilide in patients with congestive heart failure and left ventricular dysfunction.N Engl J Med. 1999;341:857-65. |
| 19) |
Kober L, et al. Effect of dofetilide in patients with recent myocardial infarction and left-ventricular dysfunction: a randomised trial.Lancet. 2000;356:2052-8. |
| 20) |
Fuster V, et al. ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation.J Am Coll Cardiol. 2001;38:1231-66. |
| 21) |
Pritchett EL, et al.Antiarrhythmic effects of azimilide in atrial fibrillation: efficacy and dose-response. J Am Coll Cardiol. 2000;36:794-802. |
| 22) |
Volgman AS, et al. Conversion efficacy and safety of intravenous ibutilide compared with intravenous procainamide in patients with atrial flutter or fibrillation.J Am Coll Cardiol. 1998;31:1414-9. |
| 23) |
The planning and steering committees of the AFFIRM study for the NHLBI AFFIRM investigators. Atrial fibrillation follow-up investigation of rhythm management:the AFFIRM study design. Am J Cardiol 1997 ; 79 : 1198-202. |
| 24) |
Hohnloser SH, et al. Rhythm or rate control in atrial fibrillation-Pharmacological intervention in atrial fibrillation (PIAF): a randomised trial.Lancet 2000;356:1789-94. |
| 25) |
The Research Group for Antiarrhythmic Drug Therapy. Cost-effectiveness of antiarrhythmic drugs for prevention of thromboembolism in patients with paroxysmal atrial fibrillation. Jpn Circ J. 2001;65:765-8. |